Health officials have given a life-extending drug the green light for widespread NHS, giving hope to thousands of men facing a "death sentence" from prostate cancer.
The National Institute for Health and Care Excellence (Nice) said the drug enzalutamide, also known as xtandi, should be considered for use in the treatment of men with hormone relapsed prostate cancer that has spread to other parts of the body.
Nice said in its draft guidance that it was pleased to recommend the drug, which is manufactured by Astellas Pharma, for patients who have few other treatment options left.
More top news
Heavy rain and wind for Scotland and northern parts this weekend with an amber weather warning issued and travel disruption expected.
Heavy rain continues to affect Western Scotland and Northern Ireland
A surgeon linked to two deaths and a series of botched surgeries is to return to work despite an ongoing investigation, ITV News understands